Compare IDYA & KNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IDYA | KNTK |
|---|---|---|
| Founded | 2015 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Natural Gas Distribution |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.5B |
| IPO Year | 2019 | N/A |
| Metric | IDYA | KNTK |
|---|---|---|
| Price | $34.38 | $36.04 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 11 |
| Target Price | ★ $49.18 | $48.00 |
| AVG Volume (30 Days) | 943.7K | ★ 1.1M |
| Earning Date | 02-12-2026 | 11-05-2025 |
| Dividend Yield | N/A | ★ 8.72% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.42 |
| Revenue | $214,834,000.00 | ★ $1,719,686,000.00 |
| Revenue This Year | $2,662.86 | $26.57 |
| Revenue Next Year | N/A | $17.00 |
| P/E Ratio | ★ N/A | $85.96 |
| Revenue Growth | ★ 5377.66 | 18.92 |
| 52 Week Low | $13.45 | $31.33 |
| 52 Week High | $37.08 | $67.60 |
| Indicator | IDYA | KNTK |
|---|---|---|
| Relative Strength Index (RSI) | 52.00 | 53.90 |
| Support Level | $33.11 | $35.05 |
| Resistance Level | $34.45 | $35.99 |
| Average True Range (ATR) | 1.14 | 1.14 |
| MACD | -0.08 | 0.11 |
| Stochastic Oscillator | 44.14 | 52.05 |
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
Kinetik Holdings Inc is a midstream operator that provides gathering and processing services to gas and oil producers as well as pipeline transportation. In addition to directly operating pipelines, Kinetik also holds ownership stakes in several pipelines. The company operates in two reportable segments which include The Midstream Logistics segment operates under three service offerings, 1) gas gathering and processing, 2) crude oil gathering, stabilization, and storage services, and 3) produced water gathering and disposal. The Pipeline Transportation segment consists of three EMI pipelines originating in the Permian Basin with various access points to the U.S. Gulf Coast, Kinetik NGL Pipelines, and Delaware Link Pipeline.